Effects of dapagliflozin on hospitalisations in people with type 2 diabetes: post-hoc analyses of the DECLARE-TIMI 58 trial

Meir Schechter, Stephen D. Wiviott, Itamar Raz, Erica L. Goodrich, Aliza Rozenberg, Ilan Yanuv, Sabina A. Murphy, Thomas A. Zelniker, Martin Fredriksson, Peter A. Johansson, Lawrence A. Leiter, Deepak L. Bhatt, Darren K. McGuire, John P.H. Wilding, Ingrid A.M. Gause-Nilsson, Avivit Cahn, Anna Maria Langkilde, Marc S. Sabatine, Ofri Mosenzon